HCA$473.79
Chart
Performance
Key Stats
AI HCA Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
BuyHCA Healthcare exhibits strong fundamental performance with consistent revenue and profit growth, coupled with a robust balance sheet. Its position in the healthcare sector provides stable, long-term thematic tailwinds. While recent technicals show some choppiness, the overall trend remains positive, suggesting a favorable outlook for investors.
Thematic
The healthcare sector, particularly hospital and healthcare services, benefits from long-term demographic trends (aging population) and increased demand for medical services. HCA's scale and diversification across various healthcare offerings position it well to capture this growth.
Fundamental
HCA Healthcare demonstrates strong profitability, consistent revenue growth, and a healthy balance sheet. Its valuation ratios are reasonable within the context of its industry and growth prospects.
Technical
The stock has experienced recent volatility. While above key long-term moving averages, it's facing resistance and showing mixed signals from oscillators, suggesting a period of consolidation or potential short-term weakness.
| Factor | Score |
|---|---|
| Aging Population | 90 |
| Healthcare Spending Growth | 85 |
| Technological Advancements in Healthcare | 70 |
| Regulatory Environment | 65 |
| Market Leadership | 80 |
| Factor | Score |
|---|---|
| Valuation | 65 |
| Profitability | 85 |
| Growth | 70 |
| Balance Sheet Health | 80 |
| Cash Flow | 90 |
| Factor | Score |
|---|---|
| Trend Analysis | 70 |
| Momentum | 50 |
| Volume Confirmation | 60 |
| Support & Resistance | 75 |
AI Investing Checklist
Powered by LiveAIBullish Points (6)
Consistently Beat Earnings Estimates
The company has exceeded earnings per share (EPS) estimates in the last 4 reported quarters, demonstrating consistent operational performance and profitability.
Undervalued Compared to Industry Peers
The P/S ratio of 1.7 is lower than the industry average of 2.5, suggesting the stock may be undervalued relative to its revenue generation.
Bearish Points (7)
High Price-to-Earnings Ratio
The trailing P/E ratio is 21.0, which is higher than the industry average, potentially indicating the stock is overvalued.
Slowing Revenue Growth
Annual revenue growth has slowed from 11.8% in 2021 to 8.2% in the latest period, indicating a potential slowdown in top-line expansion.
Calendar
June 2025
16
Ex-Dividend Date
June 2025
30
Next Dividend Date
July 2025
25
Next Earnings Date
H: $6.70
A: $6.32
L: $5.98
H: 18.85B
A: 18.50B
L: 18.16B
Profile
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Seasonals
Price Target
391.54 USD
The 39 analysts offering 1 year price forecasts for HCA have a max estimate of 444.00 and a min estimate of 316.00.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 98
A primary direct competitor operating acute care hospitals and behavioral health facilities, often in similar markets as HCA.
Weight: 96
A major direct competitor operating acute care hospitals, ambulatory surgery centers, and other healthcare facilities across the U.S.
Weight: 94
A significant direct competitor operating general acute care hospitals and related healthcare services, similar to HCA's core business.
Weight: 89
A leading distributor of pharmaceuticals and medical supplies, and a provider of healthcare information technology, essential for HCA's hospital operations.